Researchers have determined endoscopic surveillance of Barrett's esophagus does not decrease the mortality risk of esophageal cancer, according to a study in Gastroenterology.
Researchers looked at 38 patients with BE who died from adenocarcinoma and 101 who did not. They were unable to link surveillance at three years and survival rates.
More Articles on Gastroenterology:
Bariatric Surgery Does Not Reduce Long Term Healthcare Costs, Study Says
EndoChoice's Fuse System Cuts Down on Missed Colon Adenomas, Study Shows
Applied Proteomics Raises $28M to Commercialize Colon Cancer Detection Method